SPY328.64-0.16 -0.05%
DIA266.40-0.32 -0.12%
IXIC10,906.81+4.01 0.04%

Raymond James Maintains Outperform on GenMark Diagnostics, Raises Price Target to $9

Raymond James maintains GenMark Diagnostics (NASDAQ:GNMK) with a Outperform and raises the price target from $8 to $9.

Benzinga · -

Raymond James maintains GenMark Diagnostics (NASDAQ:GNMK) with a Outperform and raises the price target from $8 to $9.